Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Black Diamond Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Black Diamond Therapeutics Inc. June 6, 202496.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 30, 2025 | Black Diamond Therapeutics Inc. | Grant or award | +75,000 | — | — |
| Sep 15, 2023 | Black Diamond Therapeutics Inc. | Grant or award | +5,208 | $3.60 | $18,749 |
| Jun 16, 2023 | Black Diamond Therapeutics Inc. | Grant or award | +8,929 | $2.10 | $18,751 |
| Mar 16, 2023 | Black Diamond Therapeutics Inc. | Grant or award | +11,228 | $1.67 | $18,751 |
Questions about Mark A. Velleca
What boards is Mark A. Velleca on?
Mark A. Velleca sits on the board of Black Diamond Therapeutics Inc.
What company is Mark A. Velleca the CEO of?
Mark A. Velleca is PRESIDENT & CEO of Black Diamond Therapeutics Inc.
How long has Mark A. Velleca served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.